BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29728875)

  • 21. Optic atrophy in Wolfram (DIDMOAD) syndrome.
    Barrett TG; Bundey SE; Fielder AR; Good PA
    Eye (Lond); 1997; 11 ( Pt 6)():882-8. PubMed ID: 9537152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus, diabetes insipidus, optic atrophy and deafness (DIDMOAD syndrome).
    Saatçi U; Söylemezoğlu O; Ozen S; Yordam N; Saatçi O
    Turk J Pediatr; 1990; 32(3):211-5. PubMed ID: 2093258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives.
    Pallotta MT; Tascini G; Crispoldi R; Orabona C; Mondanelli G; Grohmann U; Esposito S
    J Transl Med; 2019 Jul; 17(1):238. PubMed ID: 31337416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wolfram Syndrome 1: From Genetics to Therapy.
    Rigoli L; Caruso V; Salzano G; Lombardo F
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Wolfram syndrome. Clinical and genetic study in two families].
    Lou Frances G; Soto de Ruiz S; López-Madrazo Hernández MJ; Macipe Costa R; Rodríguez Rigual M
    An Pediatr (Barc); 2008 Jan; 68(1):54-7. PubMed ID: 18194629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype.
    Jagomäe T; Seppa K; Reimets R; Pastak M; Plaas M; Hickey MA; Kukker KG; Moons L; De Groef L; Vasar E; Kaasik A; Terasmaa A; Plaas M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wolfram (DIDMOAD) syndrome.
    Barrett TG; Bundey SE
    J Med Genet; 1997 Oct; 34(10):838-41. PubMed ID: 9350817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three cases of didmoad or Wolfram's syndrome: urological aspects.
    Thanos A; Farmakis A; Sami Z; Davillas E; Davillas N
    J Urol; 1992 Jul; 148(1):150-2. PubMed ID: 1613861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optic atrophy as a sign of wolfram syndrome.
    Dedes W; Wildberger H; Landau K
    Klin Monbl Augenheilkd; 2005 Mar; 222(3):248-51. PubMed ID: 15785992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wolfram syndrome: case report and review of the literature.
    Ari S; Keklíkçí U; Caça I; Unlü K; Kayabaşi H
    Ann Ophthalmol (Skokie); 2007; 39(1):53-5. PubMed ID: 17914206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wolfram's (DIDMOAD) syndrome and its urological manifestation.
    Aboseif S; Gasparini M; Schmidt R; Tanagho E
    Br J Urol; 1993 Jul; 72(1):106-11. PubMed ID: 8149155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current developments in Wolfram syndrome.
    Ganie MA; Bhat D
    J Pediatr Endocrinol Metab; 2009 Jan; 22(1):3-10. PubMed ID: 19344068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature.
    Simsek E; Simsek T; Tekgül S; Hosal S; Seyrantepe V; Aktan G
    Acta Paediatr; 2003; 92(1):55-61. PubMed ID: 12650300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Wolfram syndrome. Personal experience].
    Marietti G; Bizzarri C; Perrone F; Zampino G; Conti G; Falsini B; Ricci B
    Minerva Pediatr; 1995 Apr; 47(4):127-30. PubMed ID: 7643810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine and metabolic aspects of the Wolfram syndrome.
    Boutzios G; Livadas S; Marinakis E; Opie N; Economou F; Diamanti-Kandarakis E
    Endocrine; 2011 Aug; 40(1):10-3. PubMed ID: 21725703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Various clinical aspects of DIDMOAD (Wolfram) syndrome.
    Okten A; Gedik Y; Demirci A; Mocan H; Erduran E; Aslan Y
    Turk J Pediatr; 1995; 37(3):235-40. PubMed ID: 7502361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Juvenile onset diabetes mellitus, central diabetes insipidus and optic atrophy (Wolfram syndrome)--neurological findings and prognostic implications.
    Grosse Aldenhövel HB; Gallenkamp U; Sulemana CA
    Neuropediatrics; 1991 May; 22(2):103-6. PubMed ID: 1857494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paediatric Wolfram syndrome Type 1: should gonadal dysfunction be part of the diagnostic criteria?
    Frontino G; Di Tonno R; Stancampiano MR; Arrigoni F; Rigamonti A; Morotti E; Canarutto D; Bonfanti R; Russo G; Barera G; Piemonti L
    Front Endocrinol (Lausanne); 2023; 14():1155644. PubMed ID: 37383390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Uro-andrologic alterations in Wolfram syndrome].
    Fernández Rodríguez A; Gómez Balaguer M; Santolaya García JI; Canto Faubel E; Carbonell Ferrer JM; Polo Peris A
    Arch Esp Urol; 1991 Sep; 44(7):871-3. PubMed ID: 1953076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes.
    Cano A; Molines L; Valéro R; Simonin G; Paquis-Flucklinger V; Vialettes B;
    Diabetes Care; 2007 Sep; 30(9):2327-30. PubMed ID: 17536072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.